bevacizumab,atezolizumab
roche
['imbrave050', 'bevacizumab', 'atezo']
adjuvant therapy with atezolizumab and bevacizumab increased recurrence-free survival of patients with hepatocellular carcinoma following surgical resection or ablation in the imbrave050 trial. #aacr23
The mission of the American Association for Cancer Research is to prevent and cure cancer through research, education, communication, and collaboration.